68-5
81/120

) Murakoshi M, Gohda T, Suzuki Y: Circulating Tumor Necrosis Factor Receptors: A Poten‑tial Biomarker for the Progression of Diabetic Kidney Disease. Int J Mol Sci, 2020; 21: 1957.) Kobayashi T, Ueda S, Takagi M, Kihara M, Suzuki Y: Pathophysiological roles of ADMA- mediated endothelial injury in hypertensive disorders of pregnancy. Hypertens Res Preg‑nancy, 2020; 8: 40-46.) Sakuma H, Hagiwara S, Kantharidis P, Gohda T, Suzuki Y: Potential Targeting of Ranal Fibrosis in Diabetic Kidney Disease Using MicroRNAs. Front. Pharmacol, 2020; 11: 587689.) Yap DYH, McMahon LP, Hao CM, Hu N, Okada H, Suzuki Y, Kim SG, Lim SK, Varee‑sangthip K, Hung CC, Nangaku M, APSN HIF-PHI Recommendation Committee: Recom‑mendations by the Asian Pacific society of nephrology (APSN) on the appropriate use of HIF-PH inhibitors. Nephrology(Carlton), 2020; 26: 105-118.) Gauckler P, Shin JI, Alberici F, Audard V, Bruchfeld A, Busch M, Cheung CK, Crnogorac M, Delbarba E, Eller K, Faguer S, Galesic K, Griffin S, Hruskova Z, Jeyabalan A, Karras A, King C, Kohli HS, Maas R, Mayer G, Moiseev S, Muto M, Odler B, Pepper RJ, Quintana LF, Radhakrishnan J, Ramachandran R, Salama AD, Segelmark M, Tesar V, Wetzels J, Will‑cocks L, Windpessl M, Zand L, Zonozi R, Kronbichler A, RITERM study group: Ritux‑imab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?. Auto‑immun Rev, 2020; 19: 102671.Supplementation in Patients Receiving Hemo‑dialysis or Peritoneal Dialysis. Nutrients, 2020; 12: 3371. 17) Shimizu Y, Nakata J, Maiguma M, Shirotani Y, Fukuzaki H, Nohara N, Io H, Suzuki Y: Predictive Value of 1-Week Postoperative Ultrasonography Findings for the Patency Rate of Arteriovenous Fistula. Kidney Int Rep, 2020; 5: 1746-1752. 18) Nakayama M, Hamada C, Yokoyama K, Tanno Y, Matsuo N, Nakata J, Ishibashi Y, Okuzawa A, Sakamoto K, Nara T, Kakuta T, Nangaku M, Yokoo T, Suzuki Y, Miyata T: A disposable, ultra-fine endoscope for non-in‑vasive, close examination of the intraluminal surface of the peritoneal dialysis catheter and peritoneal cavity. Sci Rep, 2020; 10: 17565. 19) Yamada K, Huang Z, Raska M, Reily C, Anderson J, Suzuki H, Kiryluk K, Gharavi AG, Julian BA, Willey CD, Novak J: Leukemia inhibitory factor signaling enhances produc‑tion of galactose-deficient IgA1 in IgA nephropathy. Kidney Dis, 2020; 6: 168-180. 20) Xie J, Liu L, Mladkova N, Li Y, Ren H, Wang W, Cui Z, Lin L, Hu X, Yu X, Xu J, Liu G, Caliskan Y, Sidore C, Balderes O, Rosen RJ, Bodria M, Zanoni F, Zhang JY, Krithivasan P, Mehl K, Marasa M, Khan A, Ozay F, Canetta PA, Bomback AS, Appel GB, Sanna-Cherchi S, Sampson MG, Mariani LH, Perkowska-Pta‑sinska A, Durlik M, Mucha K, Moszczuk B, Foroncewicz B, Pączek L, Habura I, Ars E, Ballarin J, Mani LY, Vogt B, Ozturk S, Yildiz A, Seyahi N, Arikan H, Koc M, Basturk T, Karahan G, Akgul SU, Sever MS, Zhang D, Santoro D, Bonomini M, Londrino F, Gesu‑aldo L, Reiterova J, Tesar V, Izzi C, Savoldi S, Spotti D, Marcantoni C, Messa P, Galliani M, Roccatello D, Granata S, Zaza G, Lugani F, Ghiggeri G, Pisani I, Allegri L, Sprangers B, Park JH, Cho B, Kim YS, Kim DK, Suzuki H, Amoroso A, Cattran DC, Fervenza FC, Pani A, Hamilton P, Harris S, Gupta S, Cheshire C, Dufek S, Issler N, Pepper RJ, Connolly J, Powis S, Bockenhauer D, Stanescu HC, Ashman N, Loos RJF, Kenny EE, Wuttke M, Eckardt KU, Köttgen A, Hofstra JM, Coenen MJH, Kiemeney LA, Akilesh S, Kretzler M, Beck LH, Stengel B, Debiec H, Ronco P, Wetzels JFM, Zoledziewska M, Cucca F, Ionita-Laza I, Lee H, Hoxha E, Stahl RAK, Brenchley P, Scolari F, Zhao MH, Gharavi AG, Kleta R, Chen N, Kiryluk K: The genetic architecture of membranous nephropathy and its poten‑tial to improve non-invasive diagnosis. Nat Commun, 2020; 11: 1600.〈Reviews〉 1 2 3 4 5Rheumatology〈Original Articles〉* 1) Isobe M, Amano K, Arimura Y, Ishizu A, Ito S, Kaname S, Kobayashi S, Komagata Y, 531

元のページ  ../index.html#81

このブックを見る